Protagonist Therapeutics, Inc.

What is Protagonist Therapeutics, Inc. (PTGX) stock price today?

As of Dec 16, 2025, 9:00 PM UTC, Protagonist Therapeutics, Inc. (PTGX) stock is trading at $91.54. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date PTGX stock quotes for informed trading decisions.

What is Protagonist Therapeutics, Inc.'s market capitalization?

Protagonist Therapeutics, Inc. (PTGX) has a market capitalization of approximately $5.7B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Protagonist Therapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the PTGX stock price changes.

What is the 52-week range for Protagonist Therapeutics, Inc. stock?

Protagonist Therapeutics, Inc. (PTGX) stock has traded in a 52-week range of $33.70 — $96.54. The 52-week range shows the highest and lowest prices at which PTGX traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Protagonist Therapeutics, Inc. stock price to this range provides context for recent price action.

How much trading volume does Protagonist Therapeutics, Inc. stock have?

Protagonist Therapeutics, Inc. (PTGX) stock recently traded approximately 816.5K shares. Trading volume indicates market liquidity and investor interest in PTGX. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Protagonist Therapeutics, Inc. stock.

Does Protagonist Therapeutics, Inc. pay dividends to shareholders?

Yes, Protagonist Therapeutics, Inc. (PTGX) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Protagonist Therapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Protagonist Therapeutics, Inc.'s intraday price range?

Today, Protagonist Therapeutics, Inc. (PTGX) stock has traded in a range of $90.18 — $94.35. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring PTGX's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Protagonist Therapeutics, Inc. stock data?

AlphaPilot sources real-time PTGX stock quotes, fundamental financial data, and historical price charts for Protagonist Therapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Protagonist Therapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of PTGX stock performance.